Skip to content

Vietnam logo

Main menu
    • Giới thiệu
      • Sự đa dạng, công bằng và hòa nhập
      • Tầm nhìn, sứ mệnh và giá trị
      • Ban lãnh đạo
      • Ban điều hành
    • Môi trường, xã hội và quản trị
    • Chính sách và quan điểm
  • Lĩnh vực điều trị
  • Nghề nghiệp

Liên hệ

Visit Organon's LinkedIn Opens a new window Visit Organon's Instagram Opens a new window Visit Organon's YouTube Opens a new window

Back
Change Language
Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:
Giới thiệu » Ban lãnh đạo » Ban điều hành

Ban điều hành

Ban điều hành của chúng tôi quản lý những đường lối chiến lược và các hoạt động của công ty chúng tôi. Với kinh nghiệm sâu rộng và phong phú, họ đào tạo và định hướng con người mà chúng tôi trở thành và những điều mà chúng tôi đại diện cho.

Photo of Kevin Ali

Kevin Ali, Tổng giám đốc điều hành

Photo of Susanne Fiedler

Susanne Fiedler, Giám đốc thương mại

Photo of Sandra Milligan

Sandra Milligan, Giám đốc nghiên cứu và phát triển

Photo of Joseph Morrissey

Joseph Morrissey, Giám đốc bộ phận sản xuất và cung ứng

Photo of Vittorio Nisita

Vittorio Nisita, Giám đốc bộ phận dịch vụ kinh doanh toàn cầu

Photo of Geralyn Ritter

Geralyn Ritter, Giám đốc bộ phận ngoại vụ và quản trị doanh nghiệp

Photo of Aaron Falcione

Aaron Falcione, Giám đốc nhân sự

Photo of Matthew Walsh

Matthew Walsh, Giám đốc tài chính

Photo of Rachel Stahler

Rachel Stahler, Giám đốc thông tin

Photo of Deborah H. Telman

Deborah H. Telman, Giám đốc Pháp chế

Liên hệ với chúng tôi qua mạng xã hội

Linkedin icon Opens a new window Instagram icon Opens a new window YouTube icon Opens a new window
Vietnam logo

Company

  • Giới thiệu
  • Ban lãnh đạo
  • Môi trường, Xã hội và Quản trị

Contact us

  • Liên hệ
  • Global locations
  • Forward-Looking Statement
  • Điều khoản sử dụng
  • Chính sách bảo mật
  • Sitemap
  • Privacy Policy
© 2025 Organon group of companies. All rights reserved. ORGANON and the ORGANON Logo are trademarks of the Organon group of companies.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept